Combination of Immune Checkpoint Inhibitors With Vascular Endothelial Growth Factor-Targeted Agents in Advanced Gastric and Gastroesophageal Adenocarcinoma: A Systematic Review and Meta-analysis.

AiTan (rivoceranib) - Elevar Therapeutics

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Keytruda (pembrolizumab) - Merck (MSD)

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42758904

Ahmad Basharat; Junaid Huissain; Mudasar Nisar; Muhammad Ansab; Muhammad Zubair; Sameen Tahira; Umar Akram

Sep 19, 2026